Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Click Therapeutics, Inc. (United States)
Homepage:
clicktherapeutics.com
Alternate names:
Click Therapeutics,
Click Therapeutics, Inc.
ROR:
05frdy048
OpenAlex ID:
I4405268034
Works
67
Awards
2
Clickotine, A Personalized Smartphone App for Smoking Cessation: Initial Evaluation
2017
·
Brian M Iacoviello
, Joshua R Steinerman
, et al.
·
JMIR mhealth and uhealth
·
125
AAV‐mediated gene transfer of DNase I in the liver of mice with colorectal cancer reduces liver metastasis and restores local innate and adaptive immune response
2020
·
Yujia Xia
, Jiayi He
, et al.
·
Molecular Oncology
·
97
PDF
Appropriate controls for digital therapeutic clinical trials: A narrative review of control conditions in clinical trials of digital therapeutics (DTx) deploying psychosocial, cognitive, or behavioral content
2022
·
Jacqueline Lutz
, Emanuela Offidani
, et al.
·
Frontiers in Digital Health
·
94
PDF
A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress Disorder
2017
·
Sehrish Sayed
, Nicholas T Van Dam
, et al.
·
The International Journal of Neuropsychopharmacology
·
82
PDF
A pilot study of minocycline for the treatment of bipolar depression: Effects on cortical glutathione and oxidative stress in vivo
2018
·
James W. Murrough
, Kathryn M. Huryk
, et al.
·
Journal of Affective Disorders
·
56
Cognitive and behavioral components of resilience to stress
2019
·
Brian M. Iacoviello
, Dennis S. Charney
·
Elsevier eBooks
·
50
Clinical pilot study of transcranial direct current stimulation combined with Cognitive Emotional Training for medication resistant depression
2018
·
D.M. Martin
, J.Z. Teng
, et al.
·
Journal of Affective Disorders
·
48
PDF
A randomized, controlled pilot trial of the Emotional Faces Memory Task: a digital therapeutic for depression
2018
·
Brian M. Iacoviello
, James W. Murrough
, et al.
·
npj Digital Medicine
·
43
PDF
Rigorous and rapid evidence assessment in digital health with the evidence DEFINED framework
2023
·
Jordan Silberman
, Paul Wicks
, et al.
·
npj Digital Medicine
·
39
PDF
Assessing neurophysiological changes associated with combined transcranial direct current stimulation and cognitive‐emotional training for treatment‐resistant depression
2019
·
Stevan Nikolin
, Donel Martin
, et al.
·
European Journal of Neuroscience
·
25
PDF
Morphine Sulfate and Naltrexone Hydrochloride Extended-Release Capsules: Naltrexone Release, Pharmacodynamics, and Tolerability
2011
·
Franklin Johnson
·
Pain Physician
·
23
PDF
Biophilic design, neuroarchitecture and therapeutic home environments: harnessing medicinal properties of intentionally-designed spaces to enhance digital health outcomes
2025
·
Grzegorz Bulaj
, Maria Forero
, et al.
·
Frontiers in Medicine
·
18
PDF
A digital therapeutic (CT-152) as adjunct to antidepressant medication: A phase 3 randomized controlled trial (the Mirai study)
2025
·
Brian Rothman
, Mary Slomkowski
, et al.
·
Journal of Affective Disorders
·
17
Initial Evidence for Brain Plasticity Following a Digital Therapeutic Intervention for Depression
2019
·
Megan M. Hoch
, Gaelle E. Doucet
, et al.
·
Chronic Stress
·
17
Establishment and Maintenance of a Digital Therapeutic Alliance in People Living With Negative Symptoms of Schizophrenia: Two Exploratory Single-Arm Studies
2025
·
Cassandra Snipes
, Cornelia Dorner‑Ciossek
, et al.
·
JMIR Mental Health
·
14
A Quantitative Summary of The Listening Program (TLP) Efficacy Studies: What Areas Were Found to Improve by TLP Intervention?
2016
·
Sadako Vargas
, Jay R. Lucker
·
Occupational Therapy International
·
12
Evaluating the Efficacy of a Digital Therapeutic (CT-152) as an Adjunct to Antidepressant Treatment in Adults With Major Depressive Disorder: Protocol for the MIRAI Remote Study
2024
·
Brian Rothman
, Mary Slomkowski
, et al.
·
JMIR Research Protocols
·
11
Feasibility of a digital therapeutic for experiential negative symptoms of schizophrenia: results from an exploratory study
2025
·
Haig Goenjian
, Abhishek Pratap
, et al.
·
Schizophrenia
·
9
PDF
Topical Hepatocyte Growth Factor Accelerates Wound Healing and Inhibits Scarring in Experimental Corneal Injury
2025
·
Elsayed Elbasiony
, Sharad K. Mittal
, et al.
·
Cornea
·
7
Effectiveness, Engagement, and Safety of a Digital Therapeutic (CT-155/BI 3972080) for Treating Negative Symptoms in People With Schizophrenia: Protocol for the Phase 3 CONVOKE Randomized Controlled Trial
2025
·
Shaheen E Lakhan
, Cornelia Dorner-Ciossek
, et al.
·
JMIR Research Protocols
·
6
PDF
In Silico Research Is Rewriting the Rules of Drug Development: Is It the End of Human Trials?
2025
·
Shaheen E Lakhan
·
Cureus
·
6
PDF
Efficacy and Safety of a First-in-Class Investigational Prescription Digital Therapeutic for Episodic Migraine (CT-132): Phase 3 Double-Blind, Randomized, Controlled Trial (P4-12.006)
2025
·
Cassandra Snipes
, Alexander Kuka
, et al.
·
Neurology
·
6
AAV ‐mouse DNase I sustains long‐term DNase I expression in vivo and suppresses breast cancer metastasis
2024
·
Melanie Herre
, Kalyani Vemuri
, et al.
·
FASEB BioAdvances
·
6
PDF
Decoding FDA Labeling of Prescription Digital Therapeutics: A Cross-Sectional Regulatory Study
2025
·
Shaheen E Lakhan
·
Cureus
·
5
PDF
Editorial: Prescription digital therapeutics in psychiatry
2025
·
Brett M. Colbert
, Derek M. Dykxhoorn
, et al.
·
Frontiers in Psychiatry
·
4
PDF
Show more works
View as search
Works count:
67
Citation count:
2,335
Year
Topic
Type
